By Jim BlackIt’s well known that the prostate-specific antigen (PSA) test used to screen for prostate cancer is imprecise. Elevations in PSA levels may signal prostate cancer, but they also may be due to nonmalignant prostate conditions. Further complicating the screening process is that several medications and a number of other modifiable … Read More
Jim Black has served as executive editor of Cleveland Clinic’s Men’s Health Advisor newsletter since 2005. He has written about prostate diseases, men’s health, cardiovascular disease, cancer, and a wide array of other health topics for print and digital media. He is the author of Managing Your Cholesterol: Take Charge of Your Heart Health and Managing Your Blood Pressure: Proven Steps for Treating and Avoiding Hypertension, published by University Health News. He also is the update author of two Cleveland Clinic Special Health Reports—Prostate Health: Diagnosing, Preventing, and Treating Cancer and Other Diseases of the Prostate, and Arthritis: Leading a Full Life Through Diagnosis, Treatment, and Pain Relief—published by Belvoir Media Group. Also, Jim writes periodically for Cleveland Clinic Florida’s Cancer Talk newsletter. Previously, he spent 15-plus years as a newspaper staff writer and editor, and was an adjunct faculty member at Waynesburg University, in Pennsylvania.